Pharmaceutical Technology

JULY 12, 2022

A protein-based vaccine, NVX-CoV2373 is created from the genetic sequence of the SARS-CoV-2 virus’ initial strain. Following authorisation, the vaccine will be offered for free to jurisdictions, states, federal pharmacy partners and health centres that are federally qualified.

Vaccination 162

Vaccination Vaccine Protein Pharmacy 162

STAT News

AUGUST 18, 2022

Food and Drug Administration approved a new treatment that delivers a potentially permanent, genetic fix for patients with the inherited blood disorder beta thalassemia — and quite possibly a financial lifeline for its manufacturer, Bluebird Bio , STAT tells us. As always, do keep in touch. We relish your insights and tips.

Gene Therapy 98

Gene Therapy Gene FDA Approval Pharmacy 98

Scienmag

JANUARY 5, 2021

Review of the life histories of RNA viruses, their genetics, and the compounds that could disrupt them offers hope for curtailment of future pandemics Credit: Illustration: Jennifer Matthews/Scripps Oceanography Researchers at Scripps Institution of Oceanography and Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California (..)

Production 52

Production RNA Genome Genomics 52

Pharmaceutical Technology

SEPTEMBER 20, 2022

The production of commercial dose non-sterile products such as tablets, capsules, ointments, creams, and powders is rising due to their growing global demand, attributed to increasing demand for anti-ageing products, hereditary factors, genetic mutations, exposure to harmful radiation, and rising geriatric population.

Marketing 100

Marketing Drug Delivery Systems Production Containment 100

pharmaphorum

MARCH 11, 2022

One such is Everything Genetic, which has just claimed regulatory approval for its £1.99 The low-cost LFT is undercutting some rivals such as pharmacy chain Boots, which has started offering single LFT kits online for £5.99, or four for £17, although Lloyds Pharmacy is currently offering LFTs for at-home use for £1.89.

Genetics 59

Genetics Genome Genomics Pharmacy 59

Drug Patent Watch

DECEMBER 9, 2024

The Essence of Pharmacognosy: Nature’s Pharmacy Unveiled Imagine walking through a lush rainforest, surrounded by countless plant species. Let’s embark on a journey to uncover the secrets of nature’s medicine cabinet and the legal frameworks that protect these discoveries.

Medicine 97

Medicine Drugs Production Development 97

pharmaphorum

OCTOBER 7, 2021

Dr Jean-Meidi Alili is a senior pharmacist in charge of Medicines and Research at the French healthcare network for rare metabolic diseases (G2M), where he is notably involved in implementing a drugs observatory and two ‘one-stop-shops’ in research and pharmacy.

Genome 98

Genome Genomics Medicine Life Science 98

Pharma Tutor

MAY 20, 2020

Department of Pharmacy, Bengal School of Technology. (A A College of Pharmacy), Sugandha, Delhi Road Near Chuchura, Hooghly - 712102, West Bengal, India. Scott Craniodigital syndrome is believed to be inherited as an X-connected recessive genetic trait, based totally on the presence of the circumstance in males most effective.

Pharmacy 40

Pharmacy Genetics Drugs 40

Pharmaceutical Technology

JULY 14, 2022

It is estimated that there are currently more than 7,000 orphan diseases, many of which are considered life-threatening and most of which have a genetic basis. Despite this high number, orphan diseases are rare by definition, affecting around one in 2,000 people as defined by the European Union.

Drugs 147

Drugs Medicine Marketing Development 147

Scienmag

DECEMBER 11, 2020

An international study led by researchers from the Faculty of Pharmacy at the Complutense University of Madrid has identified a series of biosynthetic genes involved in the production of usnic acid in lichen, a compound showing antiviral, antioxidant, neuroprotective, antibacterial and anticancer activity.

Gene 52

Gene Scientist Pharmacy Production 52

Advarra

AUGUST 31, 2022

Institutional biosafety committees (IBCs) frequently receive questions about the proper methodology for preparing a syringe for transport from a drug room or pharmacy to the clinic where the injection will be administered. Healthcare workers are frequently taught never to recap syringes after use.

Production 52

Production Biohazard Biohazard Containment 52

pharmaphorum

APRIL 21, 2021

The Series A was led by OmniHealth Holdings, with repeat investor Takeda and Anne Wojcicki – chief executive and founder of genetic testing firm 23andMe – also contributing to the round.

Genome 59

Genome Genomics Pharmacy Clinical Trials 59

pharmaphorum

NOVEMBER 9, 2022

Haemophilia is a rare genetic bleeding disorder, occurring in one in every 5,000 (Haemophilia A) to 30,000 (Haemophilia B) male births, and is associated with an increased bleeding tendency due to a deficiency of blood clotting proteins, called coagulation factors, which are needed for the blood to clot.†. What is haemophilia? References.

Pharmacy 98

Pharmacy Doctors Doctor Development 98

Pharmaceutical Technology

APRIL 24, 2023

In an email to this news service, João Conde, PhD, professor at NOVA Medical School, Universidade NOVA de Lisboa, said advances like the mRNA vaccines serve as a testament to the breakthroughs made by science over decades of research at the junction of genetics and nanomedicine. These could feature in the next four to five years.

Drug Delivery 147

Drug Delivery Vaccination Vaccine Research 147

Delveinsight

AUGUST 26, 2021

Shape’s RNA editing technology could potentially modify the amount of a key regulatory protein in the body or treat genetic diseases. Through the collaboration, the companies focus on connecting clinical trial data with specialty pharmacy information, natural history, registry data, and broad claims databases.

Vaccination 98

Vaccination Vaccine Gene Therapy RNA 98

XTalks

SEPTEMBER 25, 2024

NPC is a rare genetic disorder that leads to progressive neurological symptoms and organ dysfunction. The FDA’s Genetic Metabolic Diseases Advisory Committee convened in the summer and voted 11 to 5 in favor of the efficacy of Zevra’s drug. However, some panel members were still not convinced of its efficacy.

Genetics 52

Genetics Drugs Trials Pharmacy 52

Advarra

OCTOBER 26, 2023

This critical task requires meticulous planning and rigorous procedures to avoid any hazards potentially arising during the journey of an IP from the controlled environment of a pharmacy or preparation room to its destination. Think about the familiar paths we traverse every day of our lives.

Production 52

Production Containment Biohazard Biohazard 52

XTalks

APRIL 23, 2024

The disjointed interactions among insurers, managed care providers, pharmacy benefit managers and clinicians hinder efficient population health management and disease prevention. . “The area of simplifying payment systems is perhaps one of the areas in most need of reform, thus innovation,” he says.

DNA 59

DNA Genome Genomics Pharmacy 59

pharmaphorum

DECEMBER 21, 2021

At the same time, more genetic data is being gathered by healthcare systems and companies, allowing for more sophisticated analysis and potential use. He also serves as haematology consultant to the NICU and genetics service and is co-director of the NIH/Johns Hopkins Pediatric Hematology/Oncology Fellowship Program.

Development 98

Development Genome Genomics Drugs 98

Advarra

JULY 28, 2022

In the case of IBC review, we’re preventing exposure to biologics such as engineered genetic materials and/or infectious agents. They provide sterile air to prevent environmental contamination of the investigational product and sterilize the exhaust air to prevent occupational exposure and environmental release of the drug.

Contamination 52

Contamination Biohazard Biohazard Production 52

The Pharma Data

OCTOBER 30, 2020

To develop REGN-COV2, Regeneron scientists evaluated thousands of fully-human antibodies produced by the company’s VelocImmune ® mice, which have been genetically modified to have a human immune system, as well as antibodies identified from humans who have recovered from COVID-19.

Production 52

Production Antibody Manufacturing Trials 52

XTalks

AUGUST 30, 2022

The return of cell therapy-iPSCs (induced pluripotent stem cells) and genetically altered delivery cells. Ancillary services are also needed, such as a pharmacy to store, prepare and deliver the IP and labs such as a CSF lab to prepare samples.”. All facilities (such as lab, pharmacy, MRI, etc.) The patients are waiting!

Trials 83

Trials Drug Delivery Drugs Gene 83

The Pharma Data

DECEMBER 17, 2020

To develop this novel medicine, Regeneron scientists evaluated thousands of fully-human antibodies produced by the company’s VelocImmune ® mice, which have been genetically modified to have a human immune system, as well as antibodies identified from humans who have recovered from COVID-19.

Antibody 52

Antibody Medicine Production Trials 52

The Pharma Data

OCTOBER 28, 2020

To develop REGN-COV2, Regeneron scientists evaluated thousands of fully-human antibodies produced by the company’s VelocImmune ® mice, which have been genetically modified to have a human immune system, as well as antibodies identified from humans who have recovered from COVID-19.

Antibody 40

Antibody Trials Production Clinical Trials 40

The Pharma Data

DECEMBER 5, 2020

For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.

Antibody 40

Antibody Production Trials Medicine 40

XTalks

NOVEMBER 1, 2024

mL, depending on the pharmacy. Why it sold so well: Zolgensma is a gene therapy classified as personalized or precision medicine, as it is designed to address specific issues arising from an individual’s unique genetic code. mL) is around $620 for a supply of 0.25

FDA Approval 85

FDA Approval Drugs Botox Sales 85

The Pharma Data

OCTOBER 27, 2020

We commenced launch activities for the Remunity Pump for Remodulin, including shipping training devices to specialty pharmacies and certain health care practitioners, and entering into agreements with specialty pharmacies to purchase Remunity Pumps and accessories and to pre-fill the Remunity cartridges exclusively with Remodulin.

Production 40

Production Sales Licensing Licensing 40

XTalks

APRIL 24, 2023

Approximately 72 percent of rare diseases are genetic, and around 70 percent of rare genetic diseases emerge in childhood. This is important since not all pharmacies and sites are eligible to prepare and administer gene therapy due to biosafety and technical reasons. There needs to be a mock run done with sites and pharmacies.

Gene Therapy 95

Gene Therapy Gene Trials Clinical Trials 95

pharmaphorum

OCTOBER 25, 2021

Lemonaid operates an on-demand platform for remotely accessing medical care and pharmacy services, including online consultations and prescription medicines delivery across the US. The transaction is expected to close before the end of the year.

DNA 111

DNA Genetics Nurses Pharmacy 111

Pharmaceutical Technology

DECEMBER 14, 2022

Local UK pharmacies are already reporting and forecasting future shortages of antibiotics to treat Strep A infections. Bacteria naturally develop resistance to antibiotics over time, through genetic mutation, horizontal gene transfer between bacteria, or because of selective pressure. Secondly, antibiotics are not a permanent solution.

Bacteria 130

Bacteria DNA Clinical Trials Clinical Trials 130

XTalks

FEBRUARY 19, 2024

The company now offers 30 key heart health medications for under $30 at more than 70,000 pharmacies nationwide. Aging, unhealthy lifestyles and genetics increase the risk of heart-related conditions. GoodRx , a leading prescription savings platform, has launched a significant initiative to tackle cardiovascular disease in the US.

Pharmacy 98

Pharmacy Genetics Sales Drugs 98

pharmaphorum

DECEMBER 7, 2021

Viagra (sildenafil) – originally developed by Pfizer – is now widely available as a generic and can even be bought from pharmacies over-the-counter in some countries. Sildenafil is also sold as Revatio to treat pulmonary artery hypertension (PAH).

Drugs 52

Drugs Clinical Trials Clinical Trials Scientist 52

The Pharma Data

JANUARY 12, 2021

For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.

Antibody 52

Antibody Production Manufacturing Clinical Trials 52

The Pharma Data

NOVEMBER 20, 2020

Progeria and Progeroid Laminopathies are separate and distinct ultra-rare, genetic, premature aging diseases that accelerate mortality in young patients. While non–progerin producing, these genetic mutations result in disease manifestations with phenotypes that have overlap with, but are distinct from, Progeria.

FDA Approval 52

FDA Approval Genetics Clinical Trials Clinical Trials 52

The Pharma Data

NOVEMBER 20, 2020

To develop this novel medicine, Regeneron scientists evaluated thousands of fully-human antibodies produced by the company’s VelocImmune® mice, which have been genetically modified to have a human immune system, as well as antibodies identified from humans who have recovered from COVID-19.

Antibody 52

Antibody Production Clinical Trials Clinical Trials 52

The Pharma Data

JANUARY 16, 2021

” He pledged to ramp up vaccination availability in pharmacies, build mobile clinics to get vaccines to underserved rural and urban communities and encourage states to expand vaccine eligibility to people 65 and older, The New York Times reported. ” A global scourge.

Vaccination 52

Vaccination Vaccine Nurses Packaging 52

The Pharma Data

NOVEMBER 21, 2020

To develop REGEN-COV2, Regeneron scientists evaluated thousands of fully-human antibodies produced by the company’s VelocImmune ® mice, which have been genetically modified to have a human immune system, as well as antibodies identified from humans who have recovered from COVID-19.

Antibody 40

Antibody Production Clinical Trials Clinical Trials 40